• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疲劳、呼吸困难和咳嗽症状群对预测肺癌幸存者临床结局的价值。

The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.

机构信息

Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

J Pain Symptom Manage. 2011 Aug;42(2):213-21. doi: 10.1016/j.jpainsymman.2010.11.005. Epub 2011 Mar 12.

DOI:10.1016/j.jpainsymman.2010.11.005
PMID:21398089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3382064/
Abstract

CONTEXT

Aggregates of concurrent symptoms, known as symptom clusters (SxCls), are reported to have prognostic capabilities beyond that of single symptom alone. A SxCl of fatigue, dyspnea, and cough has been delineated in a number of lung cancer cohorts.

OBJECTIVES

The objective of this study was to characterize this SxCl's predictive value for important clinical outcomes relative to that of its component symptoms.

METHODS

Analysis of an eight-year prospective cohort study that assessed 2405 patients with LC for self-reported symptom burden, employment status, and physical activity with the Baecke questionnaire, and overall quality of life (QoL) was undertaken using nested Cox and generalized linear multilevel mixed models. Models were adjusted for longitudinally assessed demographics, cancer progression and tobacco use, and cancer progression.

RESULTS

The SxCl, as well as its individual symptoms and symptom pairs, were all negatively associated with survival in Cox models of Years 1-3 after diagnosis. Only in Year 3 did the SxCl prognosticate survival (and then marginally) better than single symptoms or symptom pairs; fatigue was strongly associated (P≤0.0005) with survival at all time points. The SxCl was not predictive of participants' employment status, physical activity, or QoL, whereas the presence of fatigue, dyspnea, or their combination was strongly associated with these outcomes.

CONCLUSION

Fatigue and dyspnea are strongly associated with poor clinical outcomes in LC survivors; however, a SxCl that includes fatigue, dyspnea, and cough as part as its components does not appear to significantly improve their predictive capability.

摘要

背景

同时出现的症状集合,称为症状群(SxCls),据报道其预后能力超出了单个症状的能力。在许多肺癌队列中已经描述了疲劳、呼吸困难和咳嗽的 SxCl。

目的

本研究的目的是描述该 SxCl 相对于其组成症状对重要临床结局的预测价值。

方法

分析了一项为期八年的前瞻性队列研究,该研究评估了 2405 名患有 LC 的患者的自我报告症状负担、就业状况和体力活动情况,使用 Baecke 问卷评估整体生活质量(QoL),使用嵌套 Cox 和广义线性多层混合模型进行分析。模型根据纵向评估的人口统计学、癌症进展和吸烟情况以及癌症进展进行了调整。

结果

在诊断后 1-3 年的 Cox 模型中,SxCl 及其各个症状和症状对均与生存呈负相关。只有在第 3 年,SxCl 才对生存具有更好的预测作用(但仅略为显著),比单个症状或症状对更好;在所有时间点,疲劳都与生存强烈相关(P≤0.0005)。SxCl 不能预测参与者的就业状况、体力活动或 QoL,而疲劳、呼吸困难或它们的组合的存在与这些结果强烈相关。

结论

在 LC 幸存者中,疲劳和呼吸困难与不良临床结局密切相关;然而,包含疲劳、呼吸困难和咳嗽作为其组成部分的 SxCl 似乎并没有显著提高其预测能力。

相似文献

1
The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.疲劳、呼吸困难和咳嗽症状群对预测肺癌幸存者临床结局的价值。
J Pain Symptom Manage. 2011 Aug;42(2):213-21. doi: 10.1016/j.jpainsymman.2010.11.005. Epub 2011 Mar 12.
2
Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer.疲劳、呼吸困难和咳嗽是肺癌诊断后长达五年的持续症状群。
J Pain Symptom Manage. 2011 Aug;42(2):202-12. doi: 10.1016/j.jpainsymman.2010.10.257. Epub 2011 Mar 12.
3
Predictors of cough-specific and generic quality of life in sarcoidosis patients.结节病患者咳嗽特异性和一般生活质量的预测因素。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):158-168. doi: 10.36141/svdld.v37i2.9234. Epub 2020 Jun 30.
4
The Effectiveness of Qigong in Managing a Cluster of Symptoms (Breathlessness-Fatigue-Anxiety) in Patients with Lung Cancer: A Randomized Controlled Trial.气功对肺癌患者呼吸困难-疲劳-焦虑症状群管理的有效性:一项随机对照试验。
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211008253. doi: 10.1177/15347354211008253.
5
Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).阿法替尼治疗厄洛替尼或吉非替尼治疗后进展的晚期非小细胞肺癌患者的症状和生活质量获益:一项随机 IIb/III 期试验(LUX-Lung 1)的结果。
J Thorac Oncol. 2013 Feb;8(2):229-37. doi: 10.1097/JTO.0b013e3182773fce.
6
Presence of symptom clusters in surgically treated patients with esophageal cancer: implications for survival.手术治疗食管癌患者症状群的存在:对生存的影响。
Cancer. 2014 Jan 15;120(2):286-93. doi: 10.1002/cncr.28308.
7
Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer.呼吸症状和肺功能对非小细胞肺癌长期幸存者生活质量的影响。
Chest. 2004 Feb;125(2):439-45. doi: 10.1378/chest.125.2.439.
8
Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes.在诊断为 I-III 期肺癌后,严重症状持续长达一年:全省患者报告结局分析。
Lung Cancer. 2020 Apr;142:80-89. doi: 10.1016/j.lungcan.2020.02.014. Epub 2020 Feb 25.
9
Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial.肺癌呼吸窘迫症状群的管理:一项随机对照可行性试验
Support Care Cancer. 2015 Nov;23(11):3373-84. doi: 10.1007/s00520-015-2810-x. Epub 2015 Jun 26.
10
Quality of life and symptom burden among long-term lung cancer survivors.长期肺癌幸存者的生活质量和症状负担。
J Thorac Oncol. 2012 Jan;7(1):64-70. doi: 10.1097/JTO.0b013e3182397b3e.

引用本文的文献

1
Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study.补中益气汤对接受免疫检查点抑制剂治疗的非小细胞肺癌患者免疫反应和临床结局的影响:一项随机试验研究
BMC Cancer. 2025 Jul 29;25(1):1229. doi: 10.1186/s12885-025-14629-4.
2
Characterization of multidimensional dyspnea in advanced lung cancer with moderate to severe dyspnea-related functional impairment: a latent profile analysis.对伴有中度至重度呼吸困难相关功能损害的晚期肺癌患者多维呼吸困难的特征分析:一项潜在类别分析
Support Care Cancer. 2025 Jul 18;33(8):700. doi: 10.1007/s00520-025-09757-3.
3
Activity behaviours and quality of life in patients with malignant pleural effusion.恶性胸腔积液患者的活动行为与生活质量
ERJ Open Res. 2025 Feb 17;11(1). doi: 10.1183/23120541.00399-2024. eCollection 2025 Jan.
4
Prognosis and risk factor assessment of patients with advanced lung cancer with low socioeconomic status: model development and validation.低社会经济地位的晚期肺癌患者的预后和风险因素评估:模型的建立和验证。
BMC Cancer. 2024 Sep 10;24(1):1128. doi: 10.1186/s12885-024-12863-w.
5
Non-invasive surrogate markers of pulmonary hypertension are associated with poor survival in patients with cancer.非侵入性肺高血压替代标志物与癌症患者的不良预后相关。
BMJ Open Respir Res. 2024 Aug 22;11(1):e001916. doi: 10.1136/bmjresp-2023-001916.
6
Potential Therapeutic Role of Respiratory Muscle Training in Dyspnea Management of Cancer Survivors: A Narrative Review.呼吸肌训练在癌症幸存者呼吸困难管理中的潜在治疗作用:一项叙述性综述
World J Oncol. 2024 Jun;15(3):337-347. doi: 10.14740/wjon1781. Epub 2024 Apr 11.
7
G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension.葡萄糖-6-磷酸脱氢酶(G6PD)是一种与肺腺癌和肺动脉高压中的免疫浸润相关的预后生物标志物。
Aging (Albany NY). 2024 Jan 8;16(1):466-492. doi: 10.18632/aging.205381.
8
A Proposed Theory of Symptom Cluster Management.一种症状群管理的提出理论。
Belitung Nurs J. 2021 Apr 29;7(2):78-87. doi: 10.33546/bnj.1359. eCollection 2021.
9
Perioperative pregabalin reduced fatigue scores after thoracoscopic pneumonectomy in a RCT of NSCLC patients.在一项针对非小细胞肺癌患者的随机对照试验中,围手术期使用普瑞巴林可降低胸腔镜肺切除术后的疲劳评分。
Am J Cancer Res. 2023 May 15;13(5):2201-2212. eCollection 2023.
10
Safety and Efficacy of in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial.在接受免疫检查点抑制剂治疗的晚期 NSCLC 患者中 的安全性和疗效:一项多中心、双盲、随机、安慰剂对照的初步试验方案。
Int J Environ Res Public Health. 2023 Mar 3;20(5):4507. doi: 10.3390/ijerph20054507.

本文引用的文献

1
Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer.疲劳、呼吸困难和咳嗽是肺癌诊断后长达五年的持续症状群。
J Pain Symptom Manage. 2011 Aug;42(2):202-12. doi: 10.1016/j.jpainsymman.2010.10.257. Epub 2011 Mar 12.
2
Reliability and validity testing of a single-item physical activity measure.单项体力活动测量的信度和效度测试。
Br J Sports Med. 2011 Mar;45(3):203-8. doi: 10.1136/bjsm.2009.068395. Epub 2010 May 19.
3
A qualitative exploration of a respiratory distress symptom cluster in lung cancer: cough, breathlessness and fatigue.对肺癌呼吸窘迫症状群(咳嗽、呼吸困难和疲劳)的定性探讨。
Lung Cancer. 2011 Jan;71(1):94-102. doi: 10.1016/j.lungcan.2010.04.002. Epub 2010 May 2.
4
Cancer symptom clusters: old concept but new data.癌症症状群:旧概念,新数据。
Am J Hosp Palliat Care. 2010 Jun;27(4):282-8. doi: 10.1177/1049909110364048. Epub 2010 Mar 29.
5
Increasing stringency in symptom cluster research: a methodological exploration of symptom clusters in patients with inoperable lung cancer.提高症状群研究的严格性:不可切除肺癌患者症状群的方法学探索
Oncol Nurs Forum. 2009 Nov;36(6):E282-92. doi: 10.1188/09.ONF.E283-E292.
6
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.将患者报告的结果纳入由美国国立癌症研究所资助的临床试验网络所支持的癌症症状管理临床试验中。
J Clin Oncol. 2007 Nov 10;25(32):5070-7. doi: 10.1200/JCO.2007.12.7670.
7
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice.在门诊癌症诊疗中使用单项筛查工具检测具有临床意义的疲劳、疼痛、痛苦和厌食。
J Pain Symptom Manage. 2008 Jan;35(1):20-30. doi: 10.1016/j.jpainsymman.2007.02.040. Epub 2007 Oct 23.
8
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.神经肿瘤患者生活质量单项线性模拟量表评估的验证
J Pain Symptom Manage. 2007 Dec;34(6):628-38. doi: 10.1016/j.jpainsymman.2007.01.016. Epub 2007 Aug 20.
9
Symptom clusters related to specific cancers.与特定癌症相关的症状群。
Semin Oncol Nurs. 2007 May;23(2):136-41. doi: 10.1016/j.soncn.2007.01.003.
10
Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection.全肺切除术后复发性非小细胞肺癌的生存情况。
Ann Thorac Surg. 2007 Feb;83(2):409-17; discussioin 417-8. doi: 10.1016/j.athoracsur.2006.08.046.